Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Signs an Exclusive AD04 Collaboration Framework with Molteni Farmaceutici for Europe which Anticipates Nearly $60 Million in ...

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of treatments ...
Al-Monitor

Turkey’s ruling alliance welcomes Islamist parties with misogynist agendas

AL-Monitor is an award-winning media outlet covering the Middle East, valued for its independence, diversity and analysis. It is read widely by US, international and Middle East decision makers at the ...
IEEE

OPTIFADE: On the Optimization of Symbol Error Probability for D2D Communications operating over Fading Channels

Abstract: In scenarios considering next-generation wireless networks, Device-To-Device (D2D) communications have drawn focus as a potentially useful technology. D2D communication refers to the ...